Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
Date:10/24/2011

astern/2:30 p.m. Central European/5:30 a.m. Pacific Time, members of CTI's management team will host a quarterly conference call to discuss CTI's 2011 third quarter achievements and financial results.Conference Call NumbersTuesday, October 25, 2011 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-877-941-6010 (US Participants)1-480-629-9723 (International)Call-back numbers for post-listening available at 11:30 a.m. Eastern Time:1-800-406-7325 (US Participants)1-303-590-3030  (International)Passcode: 4481372#Live audio webcast at www.celltherapeutics.com will be archived for post-call listening approximately two hours after call ends.About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities. Specifically, the risks and uncertainties that could affect the development of CTI's drug candidates include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL and/or other tumors as determined by the FDA and/or the EMA, that CTI may not receive accelerated approval for pixantrone from the FDA, that CTI may not obtain a PDUFA decision date in April 2012, that approval of pixantrone in the U.S. may not occur as early as April 2012, that CTI may not receive the day 180 respo
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
2. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
8. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
9. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
10. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... news release is available in German . ... too well: with the naked eye, you can see which ... in the blur of branches through the telephoto lens for ... for researchers who are looking to study proteins, the active ... ETH Zurich,s Institute for Molecular Systems Biology, and her colleagues ...
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine ... achieved 50% enrollment of the total projected enrollment ... the safety and preliminary efficacy of the medical ... for Knee Osteoarthritis (KOA). To date the trial ... The Phase I open label clinical ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ has ... predict the adverse and therapeutic effects of a drug. ... Biology at the Genomics Laboratory, Covance, will discuss the ... when used as part of the QC process. Additionally, ... to identify key clinical targets even in complex data ...
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ultra-low ... USA, won the Outstanding New Product Award presented on ... and Environmental Repositories (ISBER) at their annual meeting in ... recognizes the company’s development and introduction of the world’s ... was presented to Global Cooling’s CEO Neill Lane by ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2
... Inc. has been named "System Integrator of the ... the worldwide competition recognizes the system integration company ... and customer satisfaction. A panel of eight industry ... integrators throughout the world. 
 (Photo: ...
... Calif. and AMSTERDAM, Jan. 5, 2012  Agendia, an ... the company has signed a contract with Blue ... The move paves the way for future in-network ... Blue Cross affiliates across the United States. Developed ...
... CMC Biologics, a leading biopharmaceutical contract manufacturing ... US 2,171,034 B1 covering a method for improving ... bioreactors. The invention is designed to optimize production ... process, wherein the bioreactor (fermenter) has an ultrafiltration ...
Cached Biology Technology:Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine 2Agendia Signs Contract with Blue Shield of California 2CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems 2
(Date:5/16/2013)... have shown a gene involved in neurodegenerative disease also ... the circadian clock. , In a study of ... called Ataxin-2, keeps the clock responsible for sleeping and ... rhythm of the fruit fly,s sleep-wake cycle is disturbed, ... the fly. , The discovery is particularly interesting ...
(Date:5/16/2013)... relationship between the heritable risk for schizophrenia and ... is commonly associated with cognitive impairments that may ... IQ may be linked to the risk for ... precede the onset of schizophrenia symptoms. Also, these ... people diagnosed with schizophrenia. , In a remarkable ...
(Date:5/16/2013)... with ,scissor hand-like, claws in fossil records and has ... , The 505 million year old fossil called ... a distant ancestor of lobsters and scorpions, was named ... as Edward Scissorhands - a movie about an artificial ... for hands. , Kooteninchela deppi is ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Genetic risk for schizophrenia is connected to reduced IQ 2Actor Johnny Depp immortalized in ancient fossil find 2
... in diving beetles ( Dytiscidae ), researchers from the ... glimpse into a bizarre and amazing world of sperm ... including joining together into conglomerates that navigate the twisted ... of the evolutionary relationships among diving beetles reveal that ...
... specific parts of the brain activate when people view particular ... turns on when the eyes glance at faces, and another ... a person looks at scenes or buildings. However, it,s been ... a category of memory that allows the brain to temporarily ...
... eliminate malaria worldwide, new strategies are needed to find ... signs of the disease. The prevalence of asymptomatic or ... percent in populations with malaria and these asymptomatic individuals ... in areas where disease transmission has declined. ...
Cached Biology News:A bug's (sex) life: Diving beetles offer unexpected clues about sexual selection 2A bug's (sex) life: Diving beetles offer unexpected clues about sexual selection 3A bug's (sex) life: Diving beetles offer unexpected clues about sexual selection 4Working memory and the brain 2'Test and Treat' model offers new strategy for eliminating malaria 2